Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trialHugues Chabriat, Usman Khan, Ute C. Marx et al.|The Lancet Neurology|2020Cited by 51